{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:22:14Z","timestamp":1790112134377,"version":"4.0.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,6]]},"DOI":"10.7759\/cureus.43053","type":"journal-article","created":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T06:19:11Z","timestamp":1691389151000},"source":"Crossref","is-referenced-by-count":30,"title":["The Role of Estrogen Therapy as a Protective Factor for Alzheimer\u2019s Disease and Dementia in Postmenopausal Women: A Comprehensive Review of the Literature"],"prefix":"10.7759","author":[{"given":"Noor","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohab","family":"Sohail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syeda Rabab","family":"Jaffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadia","family":"Siddique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berfin","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inioluwa","family":"Atowoju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alizay","family":"Imran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Whitney","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spandana","family":"Pamulapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiza","family":"Choudhry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anum","family":"Akbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uzzam Ahmed","family":"Khawaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"","author":"Peacock K","year":"2022","unstructured":"Peacock K, Ketvertis KM, Doerr C. Menopause (Nursing). StatPearls, 2022. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK568694\/."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3109\/13697137.2015.1078206","article-title":"The urogenital system and the menopause","volume":"18 Suppl 1","author":"Calleja-Agius J","year":"2015","unstructured":"Calleja-Agius J, Brincat MP. The urogenital system and the menopause. Climacteric. 2015, 18 Suppl 1:18-22. 10.3109\/13697137.2015.1078206","journal-title":"Climacteric"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2012.03.008","article-title":"Estrogen and the skeleton","volume":"23","author":"Khosla S","year":"2012","unstructured":"Khosla S, Oursler MJ, Monroe DG. Estrogen and the skeleton. Trends Endocrinol Metab. 2012, 23:576-81. 10.1016\/j.tem.2012.03.008","journal-title":"Trends Endocrinol Metab"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/nu12010202","article-title":"Menopause-associated lipid metabolic disorders and foods beneficial for postmenopausal women","volume":"12","author":"Ko SH","year":"2020","unstructured":"Ko SH, Kim HS. Menopause-associated lipid metabolic disorders and foods beneficial for postmenopausal women. Nutrients. 2020, 12:10.3390\/nu12010202","journal-title":"Nutrients"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/421746","article-title":"Biology of bone tissue: structure, function, and factors that influence bone cells","volume":"2015","author":"Florencio-Silva R","year":"2015","unstructured":"Florencio-Silva R, Sasso GR, Sasso-Cerri E, Sim\u00f5es MJ, Cerri PS. Biology of bone tissue: structure, function, and factors that influence bone cells. Biomed Res Int. 2015, 2015:421746. 10.1155\/2015\/421746","journal-title":"Biomed Res Int"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/13697137.2022.2050206","article-title":"Skin, hair and beyond: the impact of menopause","volume":"25","author":"Zouboulis CC","year":"2022","unstructured":"Zouboulis CC, Blume-Peytavi U, Kosmadaki M, Ro\u00f3 E, Vexiau-Robert D, Kerob D, Goldstein SR. Skin, hair and beyond: the impact of menopause. Climacteric. 2022, 25:434-42. 10.1080\/13697137.2022.2050206","journal-title":"Climacteric"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1023\/a:1016880127635","article-title":"The effects of estrogen replacement therapy on neuropsychological functioning in postmenopausal women with and without dementia: a critical and theoretical review","volume":"12","author":"Zec RF","year":"2002","unstructured":"Zec RF, Trivedi MA. The effects of estrogen replacement therapy on neuropsychological functioning in postmenopausal women with and without dementia: a critical and theoretical review. Neuropsychol Rev. 2002, 12:65-109. 10.1023\/a:1016880127635","journal-title":"Neuropsychol Rev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1210\/er.2001-0016","article-title":"Estrogen and cognitive functioning in women","volume":"24","author":"Sherwin BB","year":"2003","unstructured":"Sherwin BB. Estrogen and cognitive functioning in women. Endocr Rev. 2003, 24:133-51. 10.1210\/er.2001-0016","journal-title":"Endocr Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2008.08.091","article-title":"Estrogen and progestogen therapy in postmenopausal women","volume":"90","year":"2008","unstructured":"Estrogen and progestogen therapy in postmenopausal women. Fertil Steril. 2008, 90.S88-102. 10.1016\/j.fertnstert.2008.08.091","journal-title":"Fertil Steril"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004143.pub5","article-title":"Long-term hormone therapy for perimenopausal and postmenopausal women","volume":"1","author":"Marjoribanks J","year":"2017","unstructured":"Marjoribanks J, Farquhar C, Roberts H, Lethaby A, Lee J. Long-term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database Syst Rev. 2017, 1:CD004143. 10.1002\/14651858.CD004143.pub5","journal-title":"Cochrane Database Syst Rev"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200007063430103","article-title":"Primary prevention of coronary heart disease in women through diet and lifestyle","volume":"343","author":"Stampfer MJ","year":"2000","unstructured":"Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC. Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med. 2000, 343:16-22. 10.1056\/NEJM200007063430103","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2217\/whe.12.54","article-title":"Geographic differences in fractures among women","volume":"8","author":"Litwic A","year":"2012","unstructured":"Litwic A, Edwards M, Cooper C, Dennison E. Geographic differences in fractures among women. Womens Health (Lond). 2012, 8:673-84. 10.2217\/whe.12.54","journal-title":"Womens Health (Lond)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.278040","article-title":"Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials","volume":"310","author":"Manson JE","year":"2013","unstructured":"Manson JE, Chlebowski RT, Stefanick ML, et al.. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. JAMA. 2013, 310:1353-68. 10.1001\/jama.2013.278040","journal-title":"JAMA"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cdtm.2015.02.006","article-title":"Primary osteoporosis in postmenopausal women","volume":"1","author":"Ji MX","year":"2015","unstructured":"Ji MX, Yu Q. Primary osteoporosis in postmenopausal women. Chronic Dis Transl Med. 2015, 1:9-13. 10.1016\/j.cdtm.2015.02.006","journal-title":"Chronic Dis Transl Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/01.GME.0000077620.13164.62","article-title":"Efficacy of low-dose intravaginal estriol on urogenital aging in postmenopausal women","volume":"11","author":"Dessole S","year":"2004","unstructured":"Dessole S, Rubattu G, Ambrosini G, et al.. Efficacy of low-dose intravaginal estriol on urogenital aging in postmenopausal women. Menopause. 2004, 11:49-56. 10.1097\/01.GME.0000077620.13164.62","journal-title":"Menopause"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/s0029-7844(00)01115-7","article-title":"Postmenopausal hormones and incontinence: the Heart and Estrogen\/Progestin Replacement Study","volume":"97","author":"Grady D","year":"2001","unstructured":"Grady D, Brown JS, Vittinghoff E, Applegate W, Varner E, Snyder T. Postmenopausal hormones and incontinence: the Heart and Estrogen\/Progestin Replacement Study. Obstetrics and gynecology. 2001, 97:116-120. 10.1016\/s0029-7844(00)01115-7","journal-title":"Obstetrics and gynecology"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2016.09.009","article-title":"Alzheimer's disease, apolipoprotein E and hormone replacement therapy","volume":"94","author":"Depypere H","year":"2016","unstructured":"Depypere H, Vierin A, Weyers S, Sieben A. Alzheimer's disease, apolipoprotein E and hormone replacement therapy. Maturitas. 2016, 94:98-105. 10.1016\/j.maturitas.2016.09.009","journal-title":"Maturitas"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/s0301-2115(00)00373-0","article-title":"The role of estrogen replacement therapy in Alzheimer\u2019s disease","volume":"95","author":"Panidis DK","year":"2001","unstructured":"Panidis DK, Matalliotakis IM, Rousso DH, Kourtis AI, Koumantakis EE. The role of estrogen replacement therapy in Alzheimer\u2019s disease. Eur Jr Obst Gyne Repr Bio. 2001, 95:86-91. 10.1016\/s0301-2115(00)00373-0","journal-title":"Eur Jr Obst Gyne Repr Bio"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/BF03351474","article-title":"Alzheimer's disease: insights from epidemiology","volume":"13","author":"McDowell I","year":"2001","unstructured":"McDowell I. Alzheimer's disease: insights from epidemiology. Aging (Milano). 2001, 13:143-62. 10.1007\/BF03351474","journal-title":"Aging (Milano)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.4.683","article-title":"Effect of raloxifene on prevention of dementia and cognitive impairment in older women: the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial","volume":"162","author":"Yaffe K","year":"2005","unstructured":"Yaffe K, Krueger K, Cummings SR, et al.. Effect of raloxifene on prevention of dementia and cognitive impairment in older women: the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial. Am J Psychiatry. 2005, 162:683-90. 10.1176\/appi.ajp.162.4.683","journal-title":"Am J Psychiatry"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1347.020","article-title":"Estrogen bows to a new master: the role of gonadotropins in Alzheimer pathogenesis","volume":"1052","author":"Webber KM","year":"2005","unstructured":"Webber KM, Casadesus G, Marlatt MW, et al.. Estrogen bows to a new master: the role of gonadotropins in Alzheimer pathogenesis. Ann N Y Acad Sci. 2005, 1052:201-9. 10.1196\/annals.1347.020","journal-title":"Ann N Y Acad Sci"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.yfrne.2009.04.015","article-title":"Protective actions of sex steroid hormones in Alzheimer's disease","volume":"30","author":"Pike CJ","year":"2009","unstructured":"Pike CJ, Carroll JC, Rosario ER, Barron AM. Protective actions of sex steroid hormones in Alzheimer's disease. Front Neuroendocrinol. 2009, 30:239-58. 10.1016\/j.yfrne.2009.04.015","journal-title":"Front Neuroendocrinol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.24.3005","article-title":"Estrogen and dementia: insights from the Women's Health Initiative Memory Study","volume":"291","author":"Schneider LS","year":"2004","unstructured":"Schneider LS. Estrogen and dementia: insights from the Women's Health Initiative Memory Study. JAMA. 2004, 291:3005-7. 10.1001\/jama.291.24.3005","journal-title":"JAMA"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2005.06.017","article-title":"Estrogen-containing hormone therapy and Alzheimer's disease risk: understanding discrepant inferences from observational and experimental research","volume":"138","author":"Henderson VW","year":"2006","unstructured":"Henderson VW. Estrogen-containing hormone therapy and Alzheimer's disease risk: understanding discrepant inferences from observational and experimental research. Neuroscience. 2006, 138:1031-9. 10.1016\/j.neuroscience.2005.06.017","journal-title":"Neuroscience"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0089095","article-title":"Prospective randomized trial to assess effects of continuing hormone therapy on cerebral function in postmenopausal women at risk for dementia","volume":"9","author":"Rasgon NL","year":"2014","unstructured":"Rasgon NL, Geist CL, Kenna HA, Wroolie TE, Williams KE, Silverman DH. Prospective randomized trial to assess effects of continuing hormone therapy on cerebral function in postmenopausal women at risk for dementia. PLoS One. 2014, 9:e89095. 10.1371\/journal.pone.0089095","journal-title":"PLoS One"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00041.2018","article-title":"A heartfelt message, estrogen replacement therapy: use it or lose it","volume":"315","author":"Speth RC","year":"2018","unstructured":"Speth RC, D'Ambra M, Ji H, Sandberg K. A heartfelt message, estrogen replacement therapy: use it or lose it. Am J Physiol Heart Circ Physiol. 2018, 315:H1765-78. 10.1152\/ajpheart.00041.2018","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/0470870818.ch18","article-title":"Oestrogens and dementia","volume":"230","author":"Henderson VW","year":"2000","unstructured":"Henderson VW. Oestrogens and dementia. Novartis Found Symp. 2000, 230:254-65; discussion 265-73. 10.1002\/0470870818.ch18","journal-title":"Novartis Found Symp"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-200219060-00002","article-title":"Estrogen and Alzheimer's disease: the story so far","volume":"19","author":"Cholerton B","year":"2002","unstructured":"Cholerton B, Gleason CE, Baker LD, Asthana S. Estrogen and Alzheimer's disease: the story so far. Drugs Aging. 2002, 19:405-27. 10.2165\/00002512-200219060-00002","journal-title":"Drugs Aging"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2.6.647","article-title":"Oestrogen has neuroprotective effects and may reduce the risk of Alzheimer's disease","volume":"2","author":"Eberling JL","year":"2002","unstructured":"Eberling JL. Oestrogen has neuroprotective effects and may reduce the risk of Alzheimer's disease. Expert Opin Biol Ther. 2002, 2:647-57. 10.1517\/14712598.2.6.647","journal-title":"Expert Opin Biol Ther"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.162.17.1934","article-title":"The role of hormone replacement therapy in the prevention of Alzheimer disease","volume":"162","author":"Fillit HM","year":"2002","unstructured":"Fillit HM. The role of hormone replacement therapy in the prevention of Alzheimer disease. Arch Intern Med. 2002, 162:1934-42. 10.1001\/archinte.162.17.1934","journal-title":"Arch Intern Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glp128","article-title":"Brain volumes, cognitive impairment, and conjugated equine estrogens","volume":"64","author":"Espeland MA","year":"2009","unstructured":"Espeland MA, Tindle HA, Bushnell CA, et al.. Brain volumes, cognitive impairment, and conjugated equine estrogens. J Gerontol A Biol Sci Med Sci. 2009, 64:1243-50. 10.1093\/gerona\/glp128","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1347.006","article-title":"Estrogen: a neuroprotective or proinflammatory hormone? Emerging evidence from reproductive aging models","volume":"1052","author":"Sohrabji F","year":"2005","unstructured":"Sohrabji F. Estrogen: a neuroprotective or proinflammatory hormone? Emerging evidence from reproductive aging models. Ann N Y Acad Sci. 2005, 1052:75-90. 10.1196\/annals.1347.006","journal-title":"Ann N Y Acad Sci"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.5.2.389","article-title":"Hormone therapy and Alzheimer's disease: benefit or harm?","volume":"5","author":"Henderson VW","year":"2004","unstructured":"Henderson VW. Hormone therapy and Alzheimer's disease: benefit or harm?. Expert Opin Pharmacother. 2004, 5:389-406. 10.1517\/14656566.5.2.389","journal-title":"Expert Opin Pharmacother"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-022-03152-3","article-title":"The interaction between NF-\u03baB and estrogen in Alzheimer's disease","volume":"60","author":"Mishra P","year":"2023","unstructured":"Mishra P, Davies DA, Albensi BC. The interaction between NF-\u03baB and estrogen in Alzheimer's disease. Mol Neurobiol. 2023, 60:1515-26. 10.1007\/s12035-022-03152-3","journal-title":"Mol Neurobiol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2013.08.005","article-title":"Cumulative estrogen exposure, number of menstrual cycles, and Alzheimer's risk in a cohort of British women","volume":"38","author":"Fox M","year":"2013","unstructured":"Fox M, Berzuini C, Knapp LA. Cumulative estrogen exposure, number of menstrual cycles, and Alzheimer's risk in a cohort of British women. Psychoneuroendocrinology. 2013, 38:2973-82. 10.1016\/j.psyneuen.2013.08.005","journal-title":"Psychoneuroendocrinology"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2010.08.002","article-title":"Differences in regional brain metabolism associated with specific formulations of hormone therapy in postmenopausal women at risk for AD","volume":"36","author":"Silverman DH","year":"2011","unstructured":"Silverman DH, Geist CL, Kenna HA, et al.. Differences in regional brain metabolism associated with specific formulations of hormone therapy in postmenopausal women at risk for AD. Psychoneuroendocrinology. 2011, 36:502-13. 10.1016\/j.psyneuen.2010.08.002","journal-title":"Psychoneuroendocrinology"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168654","article-title":"From menopause to neurodegeneration-molecular basis and potential therapy","volume":"22","author":"Cheng YJ","year":"2021","unstructured":"Cheng YJ, Lin CH, Lane HY. From menopause to neurodegeneration-molecular basis and potential therapy. Int J Mol Sci. 2021, 22:10.3390\/ijms22168654","journal-title":"Int J Mol Sci"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/S0079-6123(10)82003-5","article-title":"Menopause and mitochondria: windows into estrogen effects on Alzheimer's disease risk and therapy","volume":"182","author":"Henderson VW","year":"2010","unstructured":"Henderson VW, Brinton RD. Menopause and mitochondria: windows into estrogen effects on Alzheimer's disease risk and therapy. Prog Brain Res. 2010, 182:77-96. 10.1016\/S0079-6123(10)82003-5","journal-title":"Prog Brain Res"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2021.101565","article-title":"Cognitive health after menopause: Does menopausal hormone therapy affect it?","volume":"35","author":"Stute P","year":"2021","unstructured":"Stute P, Wienges J, Koller AS, Giese C, Wesem\u00fcller W, Janka H, Baumgartner S. Cognitive health after menopause: Does menopausal hormone therapy affect it?. Best Pract Res Clin Endocrinol Metab. 2021, 35:101565. 10.1016\/j.beem.2021.101565","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2382-06.2007","article-title":"Estrogen regulates Bcl-w and Bim expression: role in protection against beta-amyloid peptide-induced neuronal death","volume":"27","author":"Yao M","year":"2007","unstructured":"Yao M, Nguyen TV, Pike CJ. Estrogen regulates Bcl-w and Bim expression: role in protection against beta-amyloid peptide-induced neuronal death. J Neurosci. 2007, 27:1422-33. 10.1523\/JNEUROSCI.2382-06.2007","journal-title":"J Neurosci"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1093\/epirev\/mxt008","article-title":"Postmenopausal hormone therapy is not associated with risk of all-cause dementia and Alzheimer's disease","volume":"36","author":"O'Brien J","year":"2014","unstructured":"O'Brien J, Jackson JW, Grodstein F, Blacker D, Weuve J. Postmenopausal hormone therapy is not associated with risk of all-cause dementia and Alzheimer's disease. Epidemiol Rev. 2014, 36:83-103. 10.1093\/epirev\/mxt008","journal-title":"Epidemiol Rev"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2010.11.058","article-title":"The assessment of non-feminizing estrogens for use in neuroprotection","volume":"1379","author":"Yi KD","year":"2011","unstructured":"Yi KD, Perez E, Yang S, Liu R, Covey DF, Simpkins JW. The assessment of non-feminizing estrogens for use in neuroprotection. Brain Res. 2011, 1379:61-70. 10.1016\/j.brainres.2010.11.058","journal-title":"Brain Res"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.2010.05400.x","article-title":"Hypothesis: multiple factors are associated with the lack of any beneficial effects of oestrogen-replacement therapy in the late postmenopausal stage","volume":"37","author":"Xiao M","year":"2010","unstructured":"Xiao M, Cao GL, Marshall C, Hu G. Hypothesis: multiple factors are associated with the lack of any beneficial effects of oestrogen-replacement therapy in the late postmenopausal stage. Clin Exp Pharmacol Physiol. 2010, 37:873-6. 10.1111\/j.1440-1681.2010.05400.x","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2010.05673.x","article-title":"Estrogen therapy and Alzheimer's dementia","volume":"1205","author":"Craig MC","year":"2010","unstructured":"Craig MC, Murphy DG. Estrogen therapy and Alzheimer's dementia. Ann N Y Acad Sci. 2010, 1205:245-53. 10.1111\/j.1749-6632.2010.05673.x","journal-title":"Ann N Y Acad Sci"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1216278","article-title":"Mechanisms of action of estrogen in the brain: insights from human neuroimaging and psychopharmacologic studies","volume":"27","author":"Maki PM","year":"2009","unstructured":"Maki PM, Dumas J. Mechanisms of action of estrogen in the brain: insights from human neuroimaging and psychopharmacologic studies. Semin Reprod Med. 2009, 27:250-9. 10.1055\/s-0029-1216278","journal-title":"Semin Reprod Med"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-022-01121-5","article-title":"Hormone replacement therapy is associated with improved cognition and larger brain volumes in at-risk APOE4 women: results from the European Prevention of Alzheimer's Disease (EPAD) cohort","volume":"15","author":"Saleh RN","year":"2023","unstructured":"Saleh RN, Hornberger M, Ritchie CW, Minihane AM. Hormone replacement therapy is associated with improved cognition and larger brain volumes in at-risk APOE4 women: results from the European Prevention of Alzheimer's Disease (EPAD) cohort. Alzheimers Res Ther. 2023, 15:10. 10.1186\/s13195-022-01121-5","journal-title":"Alzheimers Res Ther"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-160258","article-title":"Early postmenopausal transdermal 17\u03b2-estradiol therapy and amyloid-\u03b2 deposition","volume":"53","author":"Kantarci K","year":"2016","unstructured":"Kantarci K, Lowe VJ, Lesnick TG, et al.. Early postmenopausal transdermal 17\u03b2-estradiol therapy and amyloid-\u03b2 deposition. J Alzheimers Dis. 2016, 53:547-56. 10.3233\/JAD-160258","journal-title":"J Alzheimers Dis"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104693","article-title":"Postmenopausal hormone therapy and Alzheimer's disease, dementia, and Parkinson's disease: A systematic review and time-response meta-analysis","volume":"155","author":"Wu M","year":"2020","unstructured":"Wu M, Li M, Yuan J, et al.. Postmenopausal hormone therapy and Alzheimer's disease, dementia, and Parkinson's disease: A systematic review and time-response meta-analysis. Pharmacol Res. 2020, 155:104693. 10.1016\/j.phrs.2020.104693","journal-title":"Pharmacol Res"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-021-00878-y","article-title":"Use of hormone therapy in postmenopausal women with Alzheimer's disease: a systematic review","volume":"38","author":"Cardinali CA","year":"2021","unstructured":"Cardinali CA, Martins YA, Torr\u00e3o AS. Use of hormone therapy in postmenopausal women with Alzheimer's disease: a systematic review. Drugs Aging. 2021, 38:769-91. 10.1007\/s40266-021-00878-y","journal-title":"Drugs Aging"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000339037.76336.cf","article-title":"Postmenopausal hormone therapy and regional brain volumes: the WHIMS-MRI Study","volume":"72","author":"Resnick SM","year":"2009","unstructured":"Resnick SM, Espeland MA, Jaramillo SA, et al.. Postmenopausal hormone therapy and regional brain volumes: the WHIMS-MRI Study. Neurology. 2009, 72:135-42. 10.1212\/01.wnl.0000339037.76336.cf","journal-title":"Neurology"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.24.2947","article-title":"Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study","volume":"291","author":"Shumaker SA","year":"2004","unstructured":"Shumaker SA, Legault C, Kuller L, et al.. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA. 2004, 291:2947-58. 10.1001\/jama.291.24.2947","journal-title":"JAMA"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22239","article-title":"Timing of hormone therapy and dementia: the critical window theory revisited","volume":"69","author":"Whitmer RA","year":"2011","unstructured":"Whitmer RA, Quesenberry CP, Zhou J, Yaffe K. Timing of hormone therapy and dementia: the critical window theory revisited. Ann Neurol. 2011, 69:163-9. 10.1002\/ana.22239","journal-title":"Ann Neurol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0150834","article-title":"Effects of hormone therapy on brain volumes changes of postmenopausal women revealed by optimally-discriminative voxel-based morphometry","volume":"11","author":"Zhang T","year":"2016","unstructured":"Zhang T, Casanova R, Resnick SM, et al.. Effects of hormone therapy on brain volumes changes of postmenopausal women revealed by optimally-discriminative voxel-based morphometry. PLoS One. 2016, 11:e0150834. 10.1371\/journal.pone.0150834","journal-title":"PLoS One"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.314295","article-title":"Estrogens still represent an attractive therapeutic approach for Alzheimer's disease","volume":"17","author":"Tamagno E","year":"2022","unstructured":"Tamagno E, Guglielmotto M. Estrogens still represent an attractive therapeutic approach for Alzheimer's disease. Neural Regen Res. 2022, 17:93-4. 10.4103\/1673-5374.314295","journal-title":"Neural Regen Res"},{"key":"ref55","article-title":"Estrogen and cerebral blood flow: a mechanism to explain the impact of estrogen on the incidence and treatment of Alzheimer's disease","volume":"45","author":"Greene RA","year":"2000","unstructured":"Greene RA. Estrogen and cerebral blood flow: a mechanism to explain the impact of estrogen on the incidence and treatment of Alzheimer's disease. Int J Fertil Womens Med. 2000, 45:253-7.","journal-title":"Int J Fertil Womens Med"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1093\/jnen\/nlac119","article-title":"LATE and potential estrogen-related risk factors collected 30 years earlier:\u00a0The 90+ Study","volume":"82","author":"Paganini-Hill A","year":"2023","unstructured":"Paganini-Hill A, Montine TJ, Bukhari SA, Corrada MM, Kawas CH, Sajjadi SA. LATE and potential estrogen-related risk factors collected 30 years earlier:\u00a0The 90+ Study. J Neuropathol Exp Neurol. 2023, 82:120-6. 10.1093\/jnen\/nlac119","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.8.1055","article-title":"Estrogen and Alzheimer disease: plausible theory, negative clinical trial","volume":"283","author":"Shaywitz BA","year":"2000","unstructured":"Shaywitz BA, Shaywitz SE. Estrogen and Alzheimer disease: plausible theory, negative clinical trial. JAMA. 2000, 283:1055-6. 10.1001\/jama.283.8.1055","journal-title":"JAMA"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043205","article-title":"Is hormone replacement therapy a risk factor or a therapeutic option for Alzheimer's disease?","volume":"24","author":"Mills ZB","year":"2023","unstructured":"Mills ZB, Faull RL, Kwakowsky A. Is hormone replacement therapy a risk factor or a therapeutic option for Alzheimer's disease?. Int J Mol Sci. 2023, 24:10.3390\/ijms24043205","journal-title":"Int J Mol Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/161685-the-role-of-estrogen-therapy-as-a-protective-factor-for-alzheimers-disease-and-dementia-in-postmenopausal-women-a-comprehensive-review-of-the-literature","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:01:02Z","timestamp":1707508862000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/161685-the-role-of-estrogen-therapy-as-a-protective-factor-for-alzheimers-disease-and-dementia-in-postmenopausal-women-a-comprehensive-review-of-the-literature"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,6]]},"references-count":58,"URL":"https:\/\/doi.org\/10.7759\/cureus.43053","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,6]]}}}